You are here

Share:

About TTC

Who Are Our Customers

  • Pharmaceutical or biotechnology company representative interested in solving a specific technical issue or developing your business and building strategic alliances;
  • University researchers interested finding a collaborator or research materials;
  • non-profit organization interested in finding treatment options for patients or to promote the development of NCI technologies into novel therapies;
  • NIH Investigators interested in patenting a discovery or in need of resources to develop a technology that are not available at NIH.

Who We Are

The National Cancer Institute’s Technology Transfer Center (TTC) facilitates partnerships between our external partners and the NIH research laboratories. Our team of technology transfer specialists will apply their specialized training to help you in invention reporting, patenting, patent strategy, executing technology transfer agreements and marketing. TTC is comprised of professionals with diverse legal, scientific, and business/marketing expertise, and most have doctorate-level technical and/or legal training. 

How We Can Help You

How We Add Value to Your Partnering Efforts

Typical outcomes of partnerships with the NIH are the commercialization of therapeutics, vaccines, diagnostics, medical devices and research tools that benefit patients worldwide. You can better understand and quantify the work we do and the value we provide with our metrics:

 4,529 CTA/MTA/CDAs signed, 156 Invention Reports, 146 New licenses, 71 issued patents, 319 active CRADAs, and 64 new CRADAs.
 
 
 
Updated
Wednesday, October 11, 2017